| scholarly article | Q13442814 |
| P50 | author | Lynn E. Eberly | Q42429872 |
| Lewis Kuller | Q88077314 | ||
| Judith K. Ockene | Q113389547 | ||
| P2093 | author name string | Multiple Risk Factor Intervention Trial Research Group | |
| Roger Sherwin | |||
| Lingfeng Yang | |||
| P2860 | cites work | Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner | Q24648885 |
| Is pulmonary dysfunction the common denominator for the multiple effects of cigarette smoking? | Q39516236 | ||
| Coronary heart disease and all-causes mortality in the Multiple Risk Factor Intervention Trial: subgroup findings and comparisons with other trials | Q41487397 | ||
| Background and organization of quality control in the Multiple Risk Factor Intervention Trial | Q43432696 | ||
| Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans | Q43459056 | ||
| Cigarette smoking and mortality. MRFIT Research Group | Q44015758 | ||
| Relation of forced expiratory volume in one second (FEV1) to lung cancer mortality in the Multiple Risk Factor Intervention Trial (MRFIT). | Q45012590 | ||
| The multiple risk factor intervention trial (MRFIT). III. The model for intervention | Q49122085 | ||
| Pulmonary function in relation to cigarette smoking and smoking cessation. MRFIT Research Group. | Q50546036 | ||
| Growth rate of small lung cancers detected on mass CT screening. | Q50671057 | ||
| Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. | Q52075219 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 592-599 | |
| P577 | publication date | 2003-08-01 | |
| P1433 | published in | International Journal of Epidemiology | Q6051393 |
| P1476 | title | Pulmonary function as a predictor of lung cancer mortality in continuing cigarette smokers and in quitters | |
| P478 | volume | 32 |
| Q36801892 | Active Component of Danshen (Salvia miltiorrhiza Bunge), Tanshinone I, Attenuates Lung Tumorigenesis via Inhibitions of VEGF, Cyclin A, and Cyclin B Expressions |
| Q37103715 | Comorbidities in chronic obstructive pulmonary disease |
| Q35536822 | Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer |
| Q36203273 | Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers |
| Q35131482 | Improved patient outcome with smoking cessation: when is it too late? |
| Q47900356 | Measurement of cardiovascular and pulmonary function endpoints and other physiological effects following partial or complete substitution of cigarettes with electronic cigarettes in adult smokers |
| Q52715752 | Prognostic implication of FEV1/FVC ratio for limited-stage small cell lung cancer. |
| Q37167684 | Prognostic value of resting pulmonary function in heart failure |
| Q35928990 | Pulmonary function changes associated with cardiomegaly in chronic heart failure |
| Q35537826 | Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis |
| Q40342298 | Spirometry: a predictor of lung cancer among asbestos workers. |
| Q28385603 | Systematic review of the evidence relating FEV1 decline to giving up smoking |
| Q26826840 | Systematic review with meta-analysis of the epidemiological evidence relating FEV1 decline to lung cancer risk |
Search more.